Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2002
10/02/2002DE10111486A1 Verwendung einer oder mehrerer neuroaktiver Substanzen zur Behandlung der Parkinsonschen Krankheit Using one or more of neuroactive substances for the treatment of Parkinson's disease
10/02/2002DE10108123A1 Wirkstoffkombination Combination of active ingredients
10/02/2002DE10108122A1 Arzneimittel auf Basis von Tramadol Medicines based on tramadol
10/02/2002CN1372594A OX2 receptor homologs
10/02/2002CN1372569A Keratinocyte growth factor-2
10/02/2002CN1372568A Vaccin
10/02/2002CN1372566A Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/02/2002CN1372565A Non-aromatic estrogenic steroids with hydrocarbon substituent in position 11
10/02/2002CN1372563A Oxathiepino [6,5-b] dihydropyridines, and related compositions and methods
10/02/2002CN1372562A Imidazoimidazoles and triazoles as anti-inflammatory agents
10/02/2002CN1372560A Crystalline 1-methylcarbapenem compounds
10/02/2002CN1372559A Naphthyridine derivatives processes for their preparation their use and pharmaceutical compositions comprising them
10/02/2002CN1372557A Neurotrophin production/secretion promoting agent
10/02/2002CN1372556A Heterocyclic compound inhibiting angiogenesis
10/02/2002CN1372555A Compositions and therapeutic mehtods involving isoflavones and analogues thereof
10/02/2002CN1372547A Aminoalkoxy carbazoles for the treatment of CNS diseases
10/02/2002CN1372546A Fused pyrrolecarboxamides GABA brain receptor ligands
10/02/2002CN1372545A 吲哚衍生物 Indole derivatives
10/02/2002CN1372544A 新颖的维生素d类似物 Novel analogues of vitamin d
10/02/2002CN1372543A new vitamin derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments
10/02/2002CN1372541A Sulfonyl carboxamide derivatives, method for their production and their use as medicaments
10/02/2002CN1372539A Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity
10/02/2002CN1372538A Method for producing a non-fatty softener based on wax-esters
10/02/2002CN1372476A Pharmaceutical composition
10/02/2002CN1372475A Combination therapy of angiotension converting enzyme inhibitor and epoxy-steroidal aldosterone anatagonist for treatment of cardiovascular disease
10/02/2002CN1372473A Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
10/02/2002CN1372470A Remedies for diabetes
10/02/2002CN1372469A Immunopotentiator
10/02/2002CN1372468A Oral preparations of etidronate disodium
10/02/2002CN1372467A Improved topical medicaments and methods for photodynamic treatment of disease
10/02/2002CN1372466A New use of docetaxel for treating hepatoma
10/02/2002CN1372465A Antimycotic drug
10/02/2002CN1372464A Naphthoquinone derivatives and their use in the treatment and control of tuberculosis
10/02/2002CN1372462A Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system
10/02/2002CN1372453A 化学去皮剂 Chemical peeling agents
10/02/2002CN1371920A Persimmon leaf polysaccharide and biological activity thereof
10/02/2002CN1371903A Optical isomer of 3-methyl fentanyl, derivant, synthesizing and its analgesic activity
10/02/2002CN1371738A Amber anti-inflammatory pain-stopping powder medicine
10/02/2002CN1371736A External medicine for treating burn and scald, soft tissue injury and skin disease
10/02/2002CN1371734A Ointment capable of quick sterilizing AIDS, veneral virus and spermatozoa and preparation process thereof
10/02/2002CN1371733A Naoan brain care capsule and preparation process thereof
10/02/2002CN1371731A Medicine for treating arthritis and bone injury disease
10/02/2002CN1371723A Anti-tumor and antiviral medicine and production method thereof
10/02/2002CN1371719A Smellting treated Chinese medicine
10/02/2002CN1371700A Medicine for treating stomatocase
10/02/2002CN1371692A Medicine for preventing tissue from adhersion after operation
10/02/2002CN1371691A Concentrated clear solution containing macrolides drug for intraveenous injection after being dilnted
10/02/2002CN1371690A Vaccine composition for initiating anti-N-glycolyl ganglioside immunoreaction and application thereof
10/02/2002CN1371689A New pharmaceutical usage of primaquine phosphate
10/02/2002CN1371688A Medicinal application of VC phosphate ester magnesium
10/02/2002CN1371687A Hypoalbuminemia improvement agent
10/02/2002CN1371686A Indomeizine external ointment for anti-inflammatory and stopping pain
10/02/2002CN1371685A Bladder irrigation original liquid
10/02/2002CN1371684A Novel biological activity of proglumide
10/02/2002CN1371683A Method for producing naproxen slow releasing capsule
10/02/2002CN1371682A Compound zinc undecylenate ointment for treating beriberi
10/02/2002CN1371681A Method for coating slow releasing coat of Ibudilast sustained micropill
10/02/2002CN1371680A Coculine osmosis pump type release-controlled preparation and preparation process thereof
10/02/2002CN1091770C Compounds useful as antiproliferative agents and GARFT inhibitors
10/02/2002CN1091769C mesylate dihydrate salts of 5-(2-(4-(1,2-benzi sothiazol-2-yl)-1-piperazinyl)-ethyl)-6-chloro-1, 3-dihydro-2(1H)-indol-2-one
10/02/2002CN1091768C Novel benzo-1,3-dioxolyl-and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
10/02/2002CN1091766C Prenyl transferase inhibitors
10/02/2002CN1091614C Bitterness-relieving agent
10/02/2002CN1091605C Markless burn and scald ointment
10/02/2002CN1091604C Processed ginseng extract having enhanced pharmacological offset and preparation method
10/02/2002CN1091602C Pertioneal dialysis solutiohns containing maltodextrins and amino acids
10/02/2002CN1091601C Use of phenol substituted diphosphonates as antineoplastic agents
10/02/2002CN1091600C Process for preparing controlled-release tablet of diltiazem hydrochloride
10/02/2002CN1091599C Anti-HIV triple combination
10/02/2002CN1091598C Pharmaceutical use of benzothiophene
10/02/2002CN1091597C Method for stabilizing pranoprofen and stable liquid preparation of pranoprofen
10/02/2002CN1091596C Anti fungal agent, compound therefor, process for producing the same
10/02/2002CN1091595C Use of a compound in preparing medicine for curing dyspepsia
10/02/2002CN1091594C Use of anti-viral compound in preparing medicine for curing virus infection
10/02/2002CN1091593C Solid pharmaceutical composition contg. benzofurnace derivs
10/02/2002CN1091592C Biological cream for treating burn and its prepn. method
10/02/2002CN1091590C Mucodhesive emulsion contg. cyclodextrin
10/02/2002CA2404775A1 Agent for treating disease due to constrictive vascular lesion
10/01/2002US6459003 Ether compounds
10/01/2002US6458998 Naphthaleneureas as antidiabetic agents
10/01/2002US6458986 Intermediate for (R)-3-(4-Bromobenzyl)-1-(3,5-dichlorophenyl)-5-iodo-3-methyl-1-H-imidazo[1,2-α]imidazol-2-one
10/01/2002US6458962 Viricides for treatment of aids and hydrogenation of compounds
10/01/2002US6458959 Anti-herpesvirus compounds and methods for identifying, making and using same
10/01/2002US6458958 Process of preparing a piperidine derivative compound of the formula: acylating an .alpha.,.alpha.-disubstituted-methylbenzene derivative having the formula:
10/01/2002US6458953 Valency platform molecules comprising carbamate linkages
10/01/2002US6458951 For treatment of male erectile dysfunction, female sexual dysfunction
10/01/2002US6458854 Administering to the mammal in the need of dry eye treatment a phospholipid-hydrkoxyeicosatetraenoic acid derivative
10/01/2002US6458853 Treating dry eye
10/01/2002US6458851 Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
10/01/2002US6458850 Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
10/01/2002US6458848 Administering to a patient suffering form autoimmune sialadenitis or sjogren's disease (autoimmune diseases) toremifene or a salt
10/01/2002US6458847 Method for screening for drugs useful in inhibition of polymerization of aβ and tau peptides
10/01/2002US6458846 Ion channel modulating agents
10/01/2002US6458845 Macrophage scavenger receptor antagonists
10/01/2002US6458844 Antiinflammatory agents
10/01/2002US6458842 Thyroid hormone or hormones; from about 40% to about 96% ethanol by volume; a ph adjusting agent so that the measured ph of the composition is from about 9 to about 12; and from about 4% to about 50% water by volume; for delivery
10/01/2002US6458841 Promoting blood circulation by topically administering of a nitric oxide intermediate, arginine, its salts, esters or complexes; warming of cold tissue, e.g., hands, feet; baldness treatent; healing of ulcers; impotence
10/01/2002US6458840 Use of valproic acid analog for the treatment and prevention of migraine and affective illness
10/01/2002US6458839 Modulation of inflammation related to columnar epithelia
10/01/2002US6458838 4-phenylbutyrate treatment of cells from both x-ald patients and x-ald knockout mice results in decreased levels of and increased .beta.-oxidation of very-long-chain fatty acids; increased expression of the peroxisomal protein aldrp; and